1.5.23 | Maternal Health
Pregnant and Lactating Populations in Research: How Leaving These Populations Out Leaves Them Behind
During this congressional briefing and national webinar, panelists explored certain areas of research where the exclusion of these groups has resulted in an inability to support them, how federal research investments could improve outcomes, and where there is opportunity—both at the legislative and regulatory level—moving forward.
1.3.23 | Autoimmune
Coverage and Access Issues Affecting Women Living with Autoimmune Diseases
In this webinar, panelists reviewed coverage and access issues that could negatively affect those with autoimmune diseases and conditions, the tenants of prior authorization and step therapy, discuss the role these policies can play in patient outcomes and on providers, and how current policies could be modified to better serve individuals.
12.21.22 | Policy
Congress Unveils FY2023 Omnibus Spending Bill
The fiscal year (FY) 2023 omnibus spending legislation (H.R. 2617) includes all 12 FY2023 spending bills including resources for advancing women's health.
12.20.22 | Autoimmune
The Growing National Burden of Autoimmune Diseases and the Role of Policy in Improving Outcomes
During this public forum, panelists discussed the disproportionate impact of autoimmune diseases and conditions on women and why tackling autoimmune diseases and conditions should be a federal priority. Following the discussion, panelists also reviewed SWHR’s newly launched autoimmune disease policy agenda.
12.13.22 | Policy
Reps. Castor, Fitzpatrick, and Underwood Introduce Legislation to Promote Greater Inclusion of Pregnant and Lactating Women in Research
Representatives Kathy Castor (D-FL), Brian Fitzpatrick (R-PA), and Lauren Underwood (D-IL) introduced H.R. 9487, the Advancing Safe Medications for Moms and Babies Act of 2022 on December 13, 2022.
12.2.22 | Autoimmune
New Autoimmune Agenda Highlights Policy Measures to Improve Outcome for Women Living with Autoimmune Diseases
The SWHR autoimmune policy agenda serves as a call to action for research, education, awareness, advocacy, clinical care, and coverage to support women impacted by autoimmune diseases and conditions.
12.2.22 | Autoimmune
Improving Outcomes for Women with Autoimmune Diseases and Conditions: A Call to Action
It is estimated that between 23.5 million and 50 million Americans are living with autoimmune diseases and conditions, and the […]
